title: Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.
abstract: Chronic hepatitis B and C represent a leading cause of morbidity and mortality among human immunodeficiency virus (HIV)-infected patients worldwide. New treatment options against both hepatitis B (HBV) and C (HCV) viruses have prompted us to update previous recommendations for the management of coinfected individuals. Fifteen topics (nine related to HCV, five to HBV and one to both viruses) were selected for this purpose. A panel of Spanish experts in the field was invited to review these areas and propose specific recommendations, which were scored according to the Infectious Disease Society of America (IDSA) grading system. These guidelines represent a comprehensive and updated overview on the management of hepatitis B and C in HIV-infected patients.
authors.affiliation: Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragonet.es
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: J M
authors.initials: JM
authors.lastname: Miró
authors.forename: J
authors.initials: J
authors.lastname: García-Samaniego
authors.forename: J
authors.initials: J
authors.lastname: Torre-Cisneros
authors.forename: M
authors.initials: M
authors.lastname: Núñez
authors.forename: J
authors.initials: J
authors.lastname: del Romero
authors.forename: L
authors.initials: L
authors.lastname: Martín-Carbonero
authors.forename: J
authors.initials: J
authors.lastname: Castilla
authors.forename: J A
authors.initials: JA
authors.lastname: Iribarren
authors.forename: C
authors.initials: C
authors.lastname: Quereda
authors.forename: M
authors.initials: M
authors.lastname: Santín
authors.forename: J
authors.initials: J
authors.lastname: González
authors.forename: J R
authors.initials: JR
authors.lastname: Arribas
authors.forename: I
authors.initials: I
authors.lastname: Santos
authors.forename: J
authors.initials: J
authors.lastname: Hernández-Quero
authors.forename: E
authors.initials: E
authors.lastname: Ortega
authors.forename: V
authors.initials: V
authors.lastname: Asensi
authors.forename: M A
authors.initials: MA
authors.lastname: del Pozo
authors.forename: J
authors.initials: J
authors.lastname: Berenguer
authors.forename: C
authors.initials: C
authors.lastname: Tural
authors.forename: B
authors.initials: B
authors.lastname: Clotet
authors.forename: M
authors.initials: M
authors.lastname: Leal
authors.forename: J
authors.initials: J
authors.lastname: Mallolas
authors.forename: J M
authors.initials: JM
authors.lastname: Sánchez-Tapias
authors.forename: S
authors.initials: S
authors.lastname: Moreno
authors.forename: J M
authors.initials: JM
authors.lastname: Gatell
authors.forename: M J
authors.initials: MJ
authors.lastname: Téllez
authors.forename: R
authors.initials: R
authors.lastname: Rubio
authors.forename: E
authors.initials: E
authors.lastname: Ledesma
authors.forename: P
authors.initials: P
authors.lastname: Domingo
authors.forename: P
authors.initials: P
authors.lastname: Barreiro
authors.forename: J
authors.initials: J
authors.lastname: Pedreira
authors.forename: M
authors.initials: M
authors.lastname: Romero
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
authors.forename: E
authors.initials: E
authors.lastname: Lissen
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D018450:Disease Progression; D018562:Disease Transmission, Infectious; D015658:HIV Infections / Q000150:complications*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D016031:Liver Transplantation; D014766:Viremia
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies